Categories
Gujarat Themis Biosyn Limited — Updates, 23-04-2026: Press Release
23-04-2026 · 11:49 pm
GTBL is acquiring Sanofi’s Global Anti-TB and Anti-Infective Portfolio for EURO 158 million. This strategic move expands GTBL's global footprint and product portfolio, targeting enhanced margins and forward integration. The acquired portfolio generated EURO 62 million in net sales in 2025.
No comments yet. Be the first to comment!